Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 20 hours 31 min ago

J&J, BMS Lose Challenges to Medicare Drug Price Negotiation Program

Tue, 04/30/2024 - 02:00
J&J, BMS Lose Challenges to Medicare Drug Price Negotiation Program 4/30/2024

AstraZeneca, Daiichi Sankyo Continue Earlier-Line Breast Cancer Push with Phase III Enhertu Win

Tue, 04/30/2024 - 02:00
AstraZeneca, Daiichi Sankyo Continue Earlier-Line Breast Cancer Push with Phase III Enhertu Win 4/30/2024

Novartis, PeptiDream Ink Potential $2.7B Deal to Expand Radioligand Discovery Partnership

Tue, 04/30/2024 - 02:00
Novartis, PeptiDream Ink Potential $2.7B Deal to Expand Radioligand Discovery Partnership 4/30/2024

Prime Medicine Gets FDA Okay for First Trial of Gene Editing Technique

Tue, 04/30/2024 - 02:00
Prime Medicine Gets FDA Okay for First Trial of Gene Editing Technique 4/30/2024

A Takeda Oncology Leader’s Passion Fuels A Patient-First Approach

Tue, 04/30/2024 - 02:00
A Takeda Oncology Leader’s Passion Fuels A Patient-First Approach 4/30/2024

Ono to Buy Deciphera for $2.4B, Looks to Expand Cancer Pipeline and US Footprint

Mon, 04/29/2024 - 02:00
Ono to Buy Deciphera for $2.4B, Looks to Expand Cancer Pipeline and US Footprint 4/29/2024

BMS, Repertoire Ink Potential $1.8B Deal to Find Vaccines for Autoimmune Diseases

Mon, 04/29/2024 - 02:00
BMS, Repertoire Ink Potential $1.8B Deal to Find Vaccines for Autoimmune Diseases 4/29/2024

FDA Approves First Targeted Treatment for WHIM Syndrome

Mon, 04/29/2024 - 02:00
FDA Approves First Targeted Treatment for WHIM Syndrome 4/29/2024

J&J-Partnered Addex Fails Phase II Epilepsy Study, Mulls Future of Candidate

Mon, 04/29/2024 - 02:00
J&J-Partnered Addex Fails Phase II Epilepsy Study, Mulls Future of Candidate 4/29/2024

Bavarian Nordic’s Mpox Vaccine Safe, Effective at Lower Doses: Study

Mon, 04/29/2024 - 02:00
Bavarian Nordic’s Mpox Vaccine Safe, Effective at Lower Doses: Study 4/29/2024

Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT

Mon, 04/29/2024 - 02:00
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT 4/29/2024

Pharma R&D ROI Spikes in 2023 as ‘Breakthroughs’ Re-Energize Industry: Report

Mon, 04/29/2024 - 02:00
Pharma R&D ROI Spikes in 2023 as ‘Breakthroughs’ Re-Energize Industry: Report 4/29/2024

What’s Next for Obesity Therapeutics? Higher Quality Weight Loss

Mon, 04/29/2024 - 02:00
What’s Next for Obesity Therapeutics? Higher Quality Weight Loss 4/29/2024

As Autism Cases Rise, Biopharma Springs Into Action

Mon, 04/29/2024 - 02:00
As Autism Cases Rise, Biopharma Springs Into Action 4/29/2024

5 Mid-Stage ALS Drugs to Watch

Mon, 04/29/2024 - 02:00
5 Mid-Stage ALS Drugs to Watch 4/29/2024

Opinion: Larimar Could Compete with Biogen in Friedreich’s Ataxia

Mon, 04/29/2024 - 02:00
Opinion: Larimar Could Compete with Biogen in Friedreich’s Ataxia 4/29/2024

AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq

Fri, 04/26/2024 - 02:00
AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq 4/26/2024

Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty

Fri, 04/26/2024 - 02:00
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty 4/26/2024

Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline

Fri, 04/26/2024 - 02:00
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline 4/26/2024

GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement

Fri, 04/26/2024 - 02:00
GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement 4/26/2024